The CJC-1295/Ipamorelin blend is studied in preclinical research on GHRH and GHRP receptor signaling, somatotroph function, growth hormone pulsatility, and IGF-1 axis dynamics
It provides an alternative option for researchers who prefer nasal administration over injections or capsules
Adverse effects observed in clinical trials include: Gastrointestinal effects: nausea, vomiting, diarrhoea, and constipation particularly during dose escalation
dosing frequency and duration depend on your diagnosis and lab values and should follow your doctors plan
Research peptides targeting these pathways are studied as tools to understand and potentially reverse molecular aging markers
Key recovery tips include managing nausea, starting with gentle activity, staying hydrated, sleeping well, and wearing compression garments as directed